A researcher at the Hackensack Meridian Center for Discovery and Innovation (CDI) and physician-scientist colleagues from Hackensack Meridian Health have shown how a critical pathway is fundamental to ...
Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients with the same disease exhibit different symptoms. Now, researchers from Japan ...
Hai-Hui "Howard" Xue, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI) have shown how a critical pathway is fundamental to the immune system, in a new papers in the journal ...
Effect of KROS 101, a small molecule GITR ligand agonist, on T effector cells, T reg cells and intratumoral CD8 T cell cytotoxicity. Phase 1 study of DK210 (EGFR), a tumor-targeted IL2 x IL10 dual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results